Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The SUV<sub>mean</sub> of the mediastinal blood uptake in patients with hypoalbuminemia and normal serum albumin were 1.6 ± 0.2 and 1.7 ± 0.3, respectively (p = 0.053).
|
31201673 |
2019 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
In this retrospective analysis, all DM patients with hypoalbuminemia (albumin < 3.5 g/dL) admitted to internal medicine "E" at Wolfson Medical Center between 1 June 2016 and 30 April 2017 were included.
|
31398808 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The 2005-2012 National Surgical Quality Improvement Program was analyzed to determine associated complications, mortality, length of stay (LOS), and readmissions for patients with hypoalbuminemia (serum albumin <3.5 g/dL and <2.8 g/dL) undergoing infrainguinal lower extremity bypass for critical limb ischemia.
|
28242402 |
2017 |
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Hip fracture patients who underwent THA and had preoperative hypoalbuminemia (<3.5 g/dL) (<i>n</i> = 569) were compared to those who had normal albumin levels (⩾3.5 g/dL) (<i>n</i> = 1098) in terms of demographics and perioperative data.
|
31304789 |
2019 |
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
We observed significantly worse patient survival (83.2% vs 90.7%, P < 0.001) and overall graft survival (72.5% vs 82.0%, P < 0.001) for recipients with hypoalbuminaemia vs normal albumin levels, respectively, but no difference in death-censored graft survival.
|
30152018 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The effect of having hypoalbuminemia (defined as albumin ≤3.5 g/dL) on selected outcomes was examined using fully adjusted multivariable models.
|
30481611 |
2018 |
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Anemia was defined when hemoglobin was <12 g/dL for women and <13 g/dL for men, and hypoalbuminemia when serum albumin was <3.5 g/dL.
|
28782162 |
2018 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Multivariate logistic regression analyses showed that HD duration, the normalized protein catabolic rate (nPCR), hypoalbuminemia (albumin < 4 g/dl), and the mean previous 12-month environmental PM2.5 were positively associated with CTS; HD duration, nPCR, hypoalbuminemia (albumin < 4 g/dl), and the mean previous 24-month environmental PM2.5 were positively associated with CTS; HD duration, hypoalbuminemia (albumin < 4 g/dl), and previous 12-month PM2.5 excess days were positively associated with CTS; and HD duration, nPCR, hypoalbuminemia (albumin < 4 g/dl), and previous 24-month PM2.5 excess days were positively associated with CTS.
|
29161700 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Albumin is often prescribed in infants with hypoalbuminemia, hyperbilirubinemia, and protein-losing conditions.
|
28739260 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The incidence of organ failure was 3.5%, 10.6%, and 41.6% in patients with normal albumin and mild and severe hypoalbuminaemia, respectively.
|
29147647 |
2017 |
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Shorter overall survival (OS) was observed in patients with hypoalbuminemia (5-year OS rate 17.1%) when compared to patients with normal serum albumin levels (5-year OS rate 58.6%, p = 0.004).
|
31468203 |
2019 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hypoalbuminemia in early onset dentatorubral-pallidoluysian atrophy due to leakage of albumin in multiple organs.
|
23263592 |
2013 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Although the biopsy population included primary and secondary glomerular disease patients, all 17 RVT patients had severe nephrotic syndrome and profound hypoalbuminemia with mean (SD) of albumin: 1.5 g/dL (0.66).
|
27796697 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Hypoalbuminemia was defined as serum albumin ≤ 2.9 g/dL.
|
31447891 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
On logistic regression analysis, age, hematuria, severe hypoalbuminemia (serum albumin <1.0 g/dL) and severe bacterial infection were not independent factors, but female sex {hazard ratio [HR] 1.5 [95% confidence interval (CI) 1.1-1.7]} and hypertension [HR 4.0 (95% CI 2.6-6.0)] were significantly related to AKI.
|
31550360 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
In theory, any additional albumin loss should be minimized because it may contribute to hypoalbuminemia and adversely affect the patient's prognosis.
|
29106652 |
2018 |
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Two weeks after commencing treatment with IVIG (2 g/kg), the median serum albumin level decreased to 3.7 g/dL (interquartile range, 3.2-4.1 g/dL) (P < .001), and the number with hypoalbuminemia increased to 60 (34.5%) of 174 (P < .001).
|
28027337 |
2017 |
Hypoalbuminemia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
While an association between hypoalbuminemia and increased risk of acute kidney injury (AKI) is well-established, the risk of AKI development and its severity among patients with elevated serum albumin is unclear.
|
29927987 |
2018 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Because preimplant hypoalbuminemia is a known risk factor for adverse outcomes, we hypothesized that change in albumin may be a prognostic indicator in patients with continuous-flow left ventricular assist devices (cfLVADs).
|
28947307 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Though median serum cholesterol values did not differ significantly between survivors and non-survivors, cats with concurrent hypoalbuminemia were at higher risk (odds ratio 15.6, 95% confidence interval 5.2-46.6; <i>P</i> <0.0001) of not surviving to discharge than cats with normal serum albumin concentrations.
|
31710272 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
On multivariate regression, severity of hypoalbuminemia was associated with increasing waitlist mortality, even after correcting for model for end stage liver disease-sodium and HCC [albumin, 2.5 to 3.4 g/dL: hazard ratio (HR), 1.81; 95% confidence interval (CI), 1.62-2.01; P<0.001; <2.5 g/dL: HR, 2.46; 95% CI, 2.20-2.76; P<0.001].
|
29356783 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
After 4 years of follow-up, Kaplan-Meier analysis showed that survival in hypoalbuminemia patients was significantly shorter than in patients with normal SA (p = 0.0393).
|
27817055 |
2017 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Compared to 30-day mortality with normal albumin on admission (2%), mortality was higher with mild (9%) and marked hypoalbuminemia (22%) and lower with hyperalbuminemia (0.4%).
|
31760678 |
2019 |
Hypoalbuminemia
|
0.500 |
Biomarker
|
disease |
BEFREE |
There is no evidence that shifts of albumin to the extravascular space or that dilution of the plasma by volume expansion plays any role in causing hypoalbuminemia in ESRD patients.
|
9848794 |
1998 |
Hypoalbuminemia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Patients were stratified by preoperative albumin level, with less than 3.5 g/dL indicating hypoalbuminemia.
|
30222797 |
2018 |